Group Therapy for Women Prisoners With Comorbid Substance Use and Depression

NCT ID: NCT00606996

Last Updated: 2025-03-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

38 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-07-31

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to determine whether interpersonal psychotherapy is effective for treating co-occurring depression and substance use among women prisoners.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Incarcerated women are a vulnerable and rapidly expanding population with high lifetime rates of both substance use disorder (SUD; abuse or dependence on alcohol, illegal drugs, or prescription drugs; 70%) and depressive disorder (DD; major depressive disorder and dysthymic disorder; 20-27%). DDs tend to worsen the course of SUDs for incarcerated women by increasing their risk for suicide attempts, contributing to the persistence of substance abuse, and reducing the likelihood of a successful transition to an independent, sober life in the community. Recent evidence indicates that DDs are common in persons with SUDs, often do not remit with SUD treatment, and should be treated. Despite growing recognition that co-occurring disorders, such as DDs, among substance abusing incarcerated women present an important public health concern, integrated treatments for SUD-DD have not been well-developed for or systematically tested in this population. Group Interpersonal Psychotherapy (IPT-G) has been shown to be efficacious in treating DD in other populations and may be especially pertinent to the needs of incarcerated women with SUD-DD because interpersonal difficulties not only affect severity of depression, but are also strong predictors of drinking to cope, SUD relapse, and prison recidivism in women.

This study tests the hypotheses that as adjuncts to prison SUD treatment, IPT-G, relative to psychoeducation on co-occurring disorders, will produce at least moderate effect sizes for:

* Reduction in the risk and severity of substance use relapse after release from prison
* Recovery from depressive disorder and reduction in depressive symptoms
* Improvement in social support and interpersonal functioning
* Reduction in the severity of legal problems during the 3 month follow-up period

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Substance Abuse Substance Dependence Depressive Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IPT-G

Group Interpersonal Psychotherapy

Group Type EXPERIMENTAL

Group interpersonal psychotherapy (IPT-G)

Intervention Type BEHAVIORAL

PSYCHOED

Psychoeducation

Group Type ACTIVE_COMPARATOR

Psychoeducation on co-occurring disorders (PSYCHOED)

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Group interpersonal psychotherapy (IPT-G)

Intervention Type BEHAVIORAL

Psychoeducation on co-occurring disorders (PSYCHOED)

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants are recruited from prison substance use treatment programs.
* Current primary (non-substance-induced, as defined by the SCID) depressive disorder (major depressive or dysthymic disorder) after at least 4 weeks of prison SUD treatment and abstinence.
* A minimum Hamilton Depression score of 18 or higher, indicating moderate to severe depression.
* Depressive disorder at any time while not incarcerated.
* Substance use disorder one month prior to incarceration.
* Between 10 and 18 weeks away from release from prison.

Exclusion Criteria

* Lifetime criteria for bipolar disorder
* Lifetime criteria for a psychotic disorder
* Actively suicidal
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Brown University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Jennifer Johnson

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jennifer E. Johnson, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Department of Psychiatry and Human Behavior, Brown University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Adult Correctional Institution

Cranston, Rhode Island, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1K23DA021159-01

Identifier Type: NIH

Identifier Source: org_study_id

View Link

NCT01831349

Identifier Type: -

Identifier Source: nct_alias

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CPT for Offenders With SUD
NCT01277939 COMPLETED NA
Marijuana Treatment Project 4
NCT02030665 COMPLETED NA